• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

European consensus statement on the prevention of venous thromboembolism. European Consensus Conference, Windsor, U.K., November, 1991.

作者信息

Haas S

机构信息

Technische Universität München, Institute für Experimentelle Chirurgie, Germany.

出版信息

Blood Coagul Fibrinolysis. 1993 Dec;4 Suppl 1:S5-8; discussion S9-10.

PMID:8180330
Abstract

Since the Consensus Conference of the National Institute of Health in 1986, the developments in the field of prevention of venous thromboembolism were mainly characterized by a more specific and extended use of new prophylactic agents such as low molecular weight heparins as well as the perception that outpatients may be at risk for thromboembolic complications, too. Therefore, in November 1991, a European Consensus Conference on the prevention of thromboembolism was held in Windsor, UK, in order to analyse the risk constellation of various patient populations and to give recommendations for primary prophylaxis in general surgery, urology, neurosurgery, orthopaedic and trauma surgery, obstetrics and gynaecology and medical patients. In addition, the cost-effectiveness of the various methods was highlighted, and the question of secondary prevention addressed. The meeting was organized under the patronage of the European Economic Commission, and experts from 15 different countries were invited to participate. The conference was organized according to acknowledged guidelines of consensus conference organization, i.e. each expert had to formulate his provisional standpoint, the working documents were compiled by the organizer, and this file was sent to the delegates before the conference. During the first part of the meeting, the delegates presented their views in plenary sessions. Controversial points were discussed in working groups, and the results were discussed in plenary sessions. Consensus or lack of accord was documented and the open questions were formulated in order to be answered by future studies. The published statements and recommendations are based on different levels of evidence.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
European consensus statement on the prevention of venous thromboembolism. European Consensus Conference, Windsor, U.K., November, 1991.
Blood Coagul Fibrinolysis. 1993 Dec;4 Suppl 1:S5-8; discussion S9-10.
2
Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK.
Int Angiol. 1992 Jul-Sep;11(3):151-9.
3
Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines.手术和产科中的静脉血栓栓塞预防:临床实践指南
Eur J Anaesthesiol. 2006 Feb;23(2):95-116. doi: 10.1017/S0265021505002164.
4
Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.低分子量肝素:外科手术患者静脉血栓栓塞的预防
Semin Hematol. 1997 Oct;34(4 Suppl 4):9-19.
5
International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997.国际共识推荐。总结声明及其他建议指南。欧洲共识会议,1991年11月。美国胸科医师学会1995年共识声明。国际共识声明,1997年。
Med Clin North Am. 1998 May;82(3):613-33. doi: 10.1016/s0025-7125(05)70014-6.
6
[The prevention of venous thromboembolism in Italy].
Minerva Chir. 1992 Oct 15;47(19):1557-61.
7
Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.依诺肝素预防普通外科手术后血栓栓塞:一项德国多中心试验。
Semin Thromb Hemost. 1993;19 Suppl 1:164-73.
8
The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.低分子量肝素在普通外科手术中预防术后静脉血栓栓塞的应用。美国的实践调查。
Int Angiol. 2002 Mar;21(1):78-85.
9
A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.一项关于新型第二代低分子肝素(苄丙酮香豆素钠)和普通肝素预防术后静脉血栓栓塞的双盲随机对照试验。苄丙酮香豆素钠评估组。
Thromb Haemost. 2000 Apr;83(4):523-9.
10
Venous thromboembolic risk and its prevention in hospitalized medical patients.住院内科患者的静脉血栓栓塞风险及其预防
Semin Thromb Hemost. 2002 Dec;28(6):577-84. doi: 10.1055/s-2002-36702.

引用本文的文献

1
Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.低分子肝素在慢性阻塞性肺疾病急性加重患者中的获益与风险:一项随机对照试验的荟萃分析。
Inflammopharmacology. 2020 Apr;28(2):451-462. doi: 10.1007/s10787-019-00659-5. Epub 2019 Oct 31.
2
Clinical experience with bemiparin.贝米肝素的临床经验。
Drugs. 2010 Dec 14;70 Suppl 2:25-33. doi: 10.2165/1158584-S0-000000000-00000.
3
Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery.
术后使用那屈肝素预防血栓栓塞事件与脊柱手术后出血风险增加无关。
Eur Spine J. 2004 Feb;13(1):9-13. doi: 10.1007/s00586-003-0642-8. Epub 2003 Nov 13.
4
Effectiveness and safety of bemiparin versus low-molecular weight heparins in orthopaedic surgery.贝米肝素与低分子量肝素在骨科手术中的有效性和安全性比较
Pharm World Sci. 2002 Jun;24(3):87-94. doi: 10.1023/a:1016187426582.
5
Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.瑞伐肝素:对其预防和治疗静脉血栓栓塞症疗效的综述
Drugs. 2001;61(8):1185-209. doi: 10.2165/00003495-200161080-00017.
6
Thrombophilia and the surgeon.易栓症与外科医生
Ann R Coll Surg Engl. 1996 Jul;78(4):331-5.